Pleural Pathologies and Malignant Effusion

  • Gregor J. Kocher
  • Ralph A. Schmid


This chapter focuses on the diagnosis and treatment of pleural disorders such as pleural effusion, pneumothorax, and pleural tumors. While in the management of benign pleural effusions, effective treatment of the underlying disease is crucial, drainage and pleurodesis are the mainstay of treatment for patients with recurrent malignant effusion. Pneumothorax, either primary or secondary, is another common pleural pathology, which often requires surgical treatment in the form of air-leak closure and pleurodesis, commonly performed by video-assisted thoracoscopic surgery (VATS). Solid tumors of the pleura are rather rare findings. Whereas pleural fibroma usually shows a benign course of disease, malignant pleural mesothelioma (MPM) is one of the most aggressive and most difficult to treat tumors of the human body. Only few cancers have caused so much controversy as MPM. For now, trimodality treatment concepts including chemotherapy, followed by extirpative surgery (e.g., extrapleural pneumonectomy or lung-sparing pleurectomy/decortication) and postoperative high-dose radiation therapy, seem to be the most promising strategy.


Pleural effusion Pneumothorax Pleurodesis Pleural fibroma Malignant pleural mesothelioma Pleurectomy decortication Extrapleural pneumonectomy 


  1. 1.
    Light RW, MacGregor MI, Luchsinger PC, et al. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med. 1972;77:507–13.CrossRefPubMedGoogle Scholar
  2. 2.
    Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev. 2004;(1):CD002916.Google Scholar
  3. 3.
    Cardillo G, Carleo F, Giunti R, et al. Videothoracoscopic talc poudrage in primary spontaneous pneumothorax: a single-institution experience in 861 cases. J Thorac Cardiovasc Surg. 2006;131(2):322–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Noppen M, Baumann MH. Pathogenesis and treatment of primary spontaneous pneumothorax: an overview. Respiration. 2003;70(4):431–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Visouli AN, Zarogoulidis K, Kougioumtzi I, et al. Catamenial pneumothorax. J Thorac Dis. 2014;6(Suppl 4):S448–60.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Robinson LA. Solitary fibrous tumor of the pleura. Cancer Control. 2006;13(4):264–9.CrossRefPubMedGoogle Scholar
  7. 7.
    Taioli E, Wolf AS, Flores RM. Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma. Ann Thorac Surg. 2015;99:472–80.CrossRefPubMedGoogle Scholar
  8. 8.
    Treasure T, Lang-Lazdunski L, Waller D, et al. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol. 2011;12(8):763–72.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag London Ltd., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Thoracic SurgeryUniversity Hospital BernBernSwitzerland

Personalised recommendations